Ketogenic Diet in Obesity and Diabetes: A Narrative Review
Nutrients · 20.06.2026 · 18 (12) · 2004
DOI: 10.3390/nu18122004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 20.06.2026. Verfasst von Yousun An und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Diabetes, Obesity and Endocrinology, Westmead Institute for Medical Research, University of Sydney, Westmead, NSW 2145, Australia. Hauptthemen laut MEDLINE: Diet, Ketogenic, Obesity, Diabetes Mellitus, Type 2, Diabetes Mellitus. Die Arbeit nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, The University of Sydney, NHMRC.
Themen: Diabetes mellitus
Abstract (Originalsprache)
A ketogenic diet (KD) is a low-carbohydrate, high-fat dietary approach. Beyond treating neurologic disorders, KDs have attracted significant media attention for their potential to improve obesity and diabetes. The diet induces a metabolic shift from glucose toward fatty acid oxidation and ketone body production. This shift leads to ketosis, which may reduce hunger, partly through the anorexigenic effects of ketone bodies, thereby contributing to weight loss and improved metabolic parameters, including glycaemic control and insulin sensitivity. In particular, the positive effects of KDs lower insulin demand and may thereby improve β-cell function. However, the long-term efficacy, safety, and sustainability of KDs, especially for diabetes, remain debated. This review offers current insights into the effects of ketogenesis and ketosis, as well as the potential mechanisms underlying them. We explore the metabolic effects of KDs in obesity and diabetes, drawing on preclinical and clinical studies, and suggest that combining KDs with antidiabetic agents may provide synergistic benefits. However, combining KDs with these pharmacotherapies, particularly SGLT-2 inhibitors, requires careful clinical supervision because of potential risks, including euglycaemic diabetic ketoacidosis. We explore how a KD alters the composition of the gut microbiota, thereby affecting host health. We conclude by highlighting challenges and future directions for optimising KD-based therapies and by outlining the limitations of the current review.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Diabetes, Obesity and Endocrinology, Westmead Institute for Medical Research, University of Sydney, Westmead, NSW 2145, Australia.
- Faculty of Medicine & Health, University of Sydney, Sydney, NSW 2006, Australia.
- Department of Diabetes and Endocrinology, Westmead Hospital, Westmead, NSW 2145, Australia.
ORCID-Profile: Yousun An, Nicholas Norris, Donglai Li, Jenny E Gunton
Förderung
- National Health and Medical Research Council
- The University of Sydney
- NHMRC
- Metabolic Health Initiative at the University of Sydney
- the Musculoskeletal Health Program at the University of Sydney
Zitieren
APA
An, Y., Norris, N., Li, D., & Gunton, J. E. (2026). Ketogenic Diet in Obesity and Diabetes: A Narrative Review. Nutrients, 18(12), 2004. https://doi.org/10.3390/nu18122004
Vancouver
An Y, Norris N, Li D, Gunton JE. Ketogenic Diet in Obesity and Diabetes: A Narrative Review. Nutrients. 2026;18(12):2004. doi:10.3390/nu18122004
BibTeX
@article{An2026,
author = {An, Yousun and Norris, Nicholas and Li, Donglai and Gunton, Jenny E},
title = {Ketogenic Diet in Obesity and Diabetes: A Narrative Review},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {12},
pages = {2004},
doi = {10.3390/nu18122004}
}
EUVIMED